Physician profile
Benjamin E Schneider
NPI 1245271816
$3,278.28
in general payments reported to CMS, 2019-2025
11 companies · $266 in 2025
The $266 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $380 · 2020: $1,018 · 2021: $19.52 · 2022: $235 · 2023: $727 · 2024: $631 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,624.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,064.33 | 2020-2023 | |
| Medtronic, INC. | $710.02 | 2022-2025 | Signia |
| Davol INC. | $451.65 | 2023-2024 | Phasix Mesh |
| Endogastric Solutions, INC | $355.15 | 2023-2024 | Esophyx |
| Aesculap, INC. | $217.89 | 2019 | |
| Enterra Medical, INC. | $146.45 | 2023 | |
| Intuitive Surgical, INC. | $108.26 | 2025 | |
| Ethicon US, LLC | $102.78 | 2019-2021 | |
| Covidien Lp | $79.19 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $29.16 | 2023 | Imcivree |
| Lilly USA, LLC | $13.40 | 2024 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Schneider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.